HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

flavasperone

inhibits ACAT2; isolated from Aspergillus; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        flavasperone: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        flavasperone: 1

Experts

1.	Abdelaziz, Tarek A: 1 article (01/2021)
2.	Abdelwahab, Ghada Mahmoud: 1 article (01/2021)
3.	Cheng, Yuan-Bin: 1 article (01/2021)
4.	Khalil, Ashraf Taha: 1 article (01/2021)
5.	Lahloub, Mohamed Farid I: 1 article (01/2021)
6.	Mira, Amira: 1 article (01/2021)

Related Diseases

1.	Alzheimer Disease (Alzheimer's Disease) 01/01/2021 - "For the first time, some isolated naphtho-γ-pyrones from marine-derived Aspergillus niger, flavasperone (1), rubrofusarin B (2), aurasperone A (3), fonsecinone A (4) in addition to one alkaloid aspernigrin A (7) were invistigated for their inhibitory activity of acetylcholine esterase AChE, a hallmark of Alzheimer's disease (AD). "

Related Drugs and Biologics

1.	Pyrones
2.	Esterases
3.	Alkaloids
4.	Acetylcholine (Acetylcholine Chloride)
5.	fonsecinone A
6.	aurasperone A
7.	aspernigrin A
8.	2,5-dichloro-4-bromophenol (B 2)
9.	rubrofusarin